DALTEPARIN SODIUM vs HEPARIN SODIUM

Compare DALTEPARIN SODIUM (Fragmin) and HEPARIN SODIUM (Heparin Sodium) — clinical data, side effects, and patient experiences.

DALTEPARIN SODIUM

Fragmin · Anticoagulant

How it works

12.1 Mechanism of Action Dalteparin is a low molecular weight heparin with antithrombotic properties. It acts by enhancing the inhibition of Factor Xa and thrombin by antithrombin....

Approved for

when concurrently administered with aspirin therapy [see Clinical Studies (14.1) ] . 1.2 Prophylaxis of Deep Vein Thrombosis FRAGMIN is indicated for the prophylaxis of deep vein thrombosis (DVT)

which may lead to pulmonary embolism (PE): • In patients undergoing hip replacement surgery [see Clinical Studies (14.2) ]

• In patients undergoing abdominal surgery who are at risk for thromboembolic complications [see Clinical Studies (14.3) ]

to reduce the recurrence of VTE in adult patients with cancer. In these patients

SubcutaneousTablet

HEPARIN SODIUM

Heparin Sodium, DEFENCATH · Anticoagulant

How it works

12.1 Mechanism of Action Heparin interacts with the naturally occurring plasma protein, Antithrombin III, to induce a conformational change, which markedly enhances the serine prot...

Approved for

1 INDICATIONS AND USAGE Heparin Sodium Injection is indicated for: Prophylaxis and treatment of venous thrombosis and pulmonary embolism

Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who

for other reasons

are at risk of developing thromboembolic disease

Intravenous, SubcutaneousTablet

Quick Comparison

DALTEPARIN SODIUMHEPARIN SODIUM

Drug Class

Anticoagulant

Route

Subcutaneous

Intravenous, Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DALTEPARIN SODIUM

Nausea

1-10%

Shortness of Breath

1-10%

Vomiting

1-10%

Abdominal Pain

1-10%

Fever

1-10%

Diarrhea

1-10%

Fatigue

1-10%

Constipation

1-10%

HEPARIN SODIUM

Drug Not Working

>10%

Nausea

1-10%

Vomiting

1-10%

Low Blood Pressure

1-10%

Shortness of Breath

1-10%

Fever

1-10%

Abdominal Pain

0.1-1%

FDA Warnings

DALTEPARIN SODIUM

5 WARNINGS AND PRECAUTIONS • Hemorrhage: Use caution in conditions with increased risk of hemorrhage ( 5
1 Risk of Hemorrhage including Spinal/Epidural Hematomas Spinal or epidural hemorrhage and subsequent hematomas can occur with the associated use of low molecular weight heparins or heparinoids and neuraxial (spinal/epidural) anesthesia or spinal puncture
The risk of these events is higher with the use of post-operative indwelling epidural catheters, with the concomitant use of additional drugs affecting hemostasis such as NSAIDs, with traumatic or repeated epidural or spinal puncture, or in patients with a history of spinal surgery or spinal deformity [see Boxed Warning , Adverse Reactions (6
To reduce the potential risk of bleeding associated with the concurrent use of FRAGMIN and epidural or spinal anesthesia/analgesia or spinal puncture, consider the pharmacokinetic profile of FRAGMIN [see Clinical Pharmacology (12

HEPARIN SODIUM

5 WARNINGS AND PRECAUTIONS Fatal Medication Errors: Confirm choice of correct strength prior to administration ( 5
1 ) Hemorrhage: Fatal cases have occurred
Use caution in conditions with increased risk of hemorrhage ( 5
6 ) Hyperkalemia: Measure blood potassium in patients at risk of hyperkalemia before starting heparin therapy and periodically in all patients ( 5

Clinical Trial Data

No head-to-head clinical studies found for DALTEPARIN SODIUM vs HEPARIN SODIUM.

DALTEPARIN SODIUM vs HEPARIN SODIUM: What You Should Know

Key Differences

Both DALTEPARIN SODIUM and HEPARIN SODIUM belong to the Anticoagulant class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. DALTEPARIN SODIUM is administered via Subcutaneous, whereas HEPARIN SODIUM uses Intravenous or Subcutaneous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

DALTEPARIN SODIUM carries 4 FDA warnings. HEPARIN SODIUM carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ENOXAPARIN SODIUM vs HEPARIN SODIUM→DALTEPARIN SODIUM vs ENOXAPARIN SODIUM→HEPARIN SODIUM vs TAUROLIDINE AND HEPARIN→DALTEPARIN SODIUM vs TAUROLIDINE AND HEPARIN→FONDAPARINUX SODIUM vs HEPARIN SODIUM→DALTEPARIN SODIUM vs FONDAPARINUX SODIUM→

Loading comparison data...

DALTEPARIN SODIUM vs HEPARIN SODIUM

Compare DALTEPARIN SODIUM (Fragmin) and HEPARIN SODIUM (Heparin Sodium) — clinical data, side effects, and patient experiences.

DALTEPARIN SODIUM

Fragmin · Anticoagulant

How it works

12.1 Mechanism of Action Dalteparin is a low molecular weight heparin with antithrombotic properties. It acts by enhancing the inhibition of Factor Xa and thrombin by antithrombin....

Approved for

when concurrently administered with aspirin therapy [see Clinical Studies (14.1) ] . 1.2 Prophylaxis of Deep Vein Thrombosis FRAGMIN is indicated for the prophylaxis of deep vein thrombosis (DVT)

which may lead to pulmonary embolism (PE): • In patients undergoing hip replacement surgery [see Clinical Studies (14.2) ]

• In patients undergoing abdominal surgery who are at risk for thromboembolic complications [see Clinical Studies (14.3) ]

to reduce the recurrence of VTE in adult patients with cancer. In these patients

SubcutaneousTablet

HEPARIN SODIUM

Heparin Sodium, DEFENCATH · Anticoagulant

How it works

12.1 Mechanism of Action Heparin interacts with the naturally occurring plasma protein, Antithrombin III, to induce a conformational change, which markedly enhances the serine prot...

Approved for

1 INDICATIONS AND USAGE Heparin Sodium Injection is indicated for: Prophylaxis and treatment of venous thrombosis and pulmonary embolism

Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who

for other reasons

are at risk of developing thromboembolic disease

Intravenous, SubcutaneousTablet

Quick Comparison

DALTEPARIN SODIUMHEPARIN SODIUM

Drug Class

Anticoagulant

Route

Subcutaneous

Intravenous, Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DALTEPARIN SODIUM

Nausea

1-10%

Shortness of Breath

1-10%

Vomiting

1-10%

Abdominal Pain

1-10%

Fever

1-10%

Diarrhea

1-10%

Fatigue

1-10%

Constipation

1-10%

HEPARIN SODIUM

Drug Not Working

>10%

Nausea

1-10%

Vomiting

1-10%

Low Blood Pressure

1-10%

Shortness of Breath

1-10%

Fever

1-10%

Abdominal Pain

0.1-1%

FDA Warnings

DALTEPARIN SODIUM

5 WARNINGS AND PRECAUTIONS • Hemorrhage: Use caution in conditions with increased risk of hemorrhage ( 5
1 Risk of Hemorrhage including Spinal/Epidural Hematomas Spinal or epidural hemorrhage and subsequent hematomas can occur with the associated use of low molecular weight heparins or heparinoids and neuraxial (spinal/epidural) anesthesia or spinal puncture
The risk of these events is higher with the use of post-operative indwelling epidural catheters, with the concomitant use of additional drugs affecting hemostasis such as NSAIDs, with traumatic or repeated epidural or spinal puncture, or in patients with a history of spinal surgery or spinal deformity [see Boxed Warning , Adverse Reactions (6
To reduce the potential risk of bleeding associated with the concurrent use of FRAGMIN and epidural or spinal anesthesia/analgesia or spinal puncture, consider the pharmacokinetic profile of FRAGMIN [see Clinical Pharmacology (12

HEPARIN SODIUM

5 WARNINGS AND PRECAUTIONS Fatal Medication Errors: Confirm choice of correct strength prior to administration ( 5
1 ) Hemorrhage: Fatal cases have occurred
Use caution in conditions with increased risk of hemorrhage ( 5
6 ) Hyperkalemia: Measure blood potassium in patients at risk of hyperkalemia before starting heparin therapy and periodically in all patients ( 5

Clinical Trial Data

No head-to-head clinical studies found for DALTEPARIN SODIUM vs HEPARIN SODIUM.

DALTEPARIN SODIUM vs HEPARIN SODIUM: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.